- cafead   Apr 11, 2022 at 10:52: AM
via Shares of Bicycle Therapeutics Inc. BCYC, -30.10% tumbled 23.4% in premarket trading on Monday after the company shared interim data from a Phase 1 clinical trial for its urothelial-cancer treatment.
article source
article source